Nucleic acid test

New CDC Guidelines Endorse Opt-Out Screening for Two of the Most Common Sexually Transmitted Infections (STIs), Recommend Nucleic Acid Testing for Mycoplasma Genitalium

Retrieved on: 
Monday, July 26, 2021
Medical devices, Medical Supplies, Women, Infectious diseases, Biotechnology, AIDS, Health, Consumer, General Health, Sexually transmitted diseases and infections, Medical specialties, Clinical medicine, Infectious causes of cancer, Medicine, Mycoplasma, Synthetic biology, Mycoplasma genitalium, Urethritis, Cervicitis, Nucleic acid test, Protein M

For the first time, CDC guidelines also defined specific populations (men with recurrent urethritis and women with recurrent cervicitis) to be tested for Mycoplasma genitalium and recommended nucleic-acid amplification testing (NAAT) for detection.

Key Points: 
  • For the first time, CDC guidelines also defined specific populations (men with recurrent urethritis and women with recurrent cervicitis) to be tested for Mycoplasma genitalium and recommended nucleic-acid amplification testing (NAAT) for detection.
  • The 2015 CDC guidelines included M. genitalium as an emerging issue, but no FDA-cleared NAATs were available at that time11.
  • Hologic was first to market in 2019 with a NAAT for M. genitalium, and Hologics Aptima Mycoplasma genitalium Assay is specifically noted in the current guidelines1.
  • No FDA-cleared M. genitalium tests are available in the U.S. that detect antibiotic resistance, although Hologic is working to develop one.

NuProbe Technology Enables Low-Frequency DNA Variant Detection using Low-depth Sequencing

Retrieved on: 
Monday, May 3, 2021
Branches of biology, Biology, Life sciences, Biotechnology, Molecular biology, DNA, Medical genetics, Molecular diagnostics, Single-nucleotide polymorphism, DNA sequencing, Nucleic acid test

b'HOUSTON, May 3, 2021 /PRNewswire/ --NuProbe Global, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing assays, announced research demonstrating the ability to detect single nucleotide variants (SNVs) in DNA with a variant allele frequency (VAF) of 0.02% using a sequencing depth of only 250x.

Key Points: 
  • b'HOUSTON, May 3, 2021 /PRNewswire/ --NuProbe Global, a genomics and molecular diagnostics company specialized in ultrasensitive sequencing assays, announced research demonstrating the ability to detect single nucleotide variants (SNVs) in DNA with a variant allele frequency (VAF) of 0.02% using a sequencing depth of only 250x.
  • This can cause the sequencing cost per-sample to be more than $1000.
  • Data from the study shows that multiplex blocker displacement amplification (mBDA), a library preparation method exclusively licensed and developed by NuProbe, allows for NGS-based detection and quantitation of DNA variants at
  • Additionally, our NGS panels have now been validated on clinical samples using a variety of sequencing platforms including those from Illumina, Ion Torrent, and Oxford Nanopore.

CDC Coronavirus Test Kits Generate 30% False Positive and 20% False Negative Results - Connecticut Pathologist’s Newly Published Findings Confirm

Retrieved on: 
Friday, July 17, 2020
Nursing, Biotechnology, FDA, Managed care, Health, Pharmaceutical, Infectious diseases, Hospitals, Genetics, Dental, Clinical trials, Branches of biology, Natural sciences, Biology, Molecular biology, Polymerase chain reaction, Laboratory techniques, Biotechnology, Amplifiers, Nucleic acid test, Severe acute respiratory syndrome-related coronavirus, Reverse transcription polymerase chain reaction, Sanger sequencing

The current CDC nucleic acid test kits for SARS-CoV-2 generate 30% false-positive and 20% false-negative results in the best state public health laboratory, Dr.

Key Points: 
  • The current CDC nucleic acid test kits for SARS-CoV-2 generate 30% false-positive and 20% false-negative results in the best state public health laboratory, Dr.
  • Sin Hang Lee reported in a peer-reviewed article published in the International Journal of Geriatrics and Rehabilitation, an online journal based in Japan ( http://www.int-soc-clin-geriat.com/info/wp-content/uploads/2020/03/Dr.-L... ), on July 17, 2020.
  • But the FDA also states, False results can be investigated using an additional EUA RT-PCR assay, and/or Sanger sequencing.
  • This indicates that Sanger sequencing is a de facto gold standard in resolving discordant nucleic acid-based test results, said Dr. Lee.

West China Hospital in Chengdu Donates COVID-19 Test Kits to Georgia

Retrieved on: 
Tuesday, March 17, 2020
Viruses, Zoonoses, Animal diseases, Branches of biology, Health in Saudi Arabia, In Saudi Arabia, Middle East respiratory syndrome, Middle East respiratory syndrome-related coronavirus, Nucleic acid test

CHENGDU, China, March 16, 2020 /PRNewswire/ -- On March 12, the West China Hospital affiliated to Sichuan University donated a batch of isothermal nucleic acid amplification microfluidic chip analyzers and nucleic acid test kits, which can detect and distinguish six respiratory viruses, including the novel coronavirus (COVID-19), to Georgian government.

Key Points: 
  • CHENGDU, China, March 16, 2020 /PRNewswire/ -- On March 12, the West China Hospital affiliated to Sichuan University donated a batch of isothermal nucleic acid amplification microfluidic chip analyzers and nucleic acid test kits, which can detect and distinguish six respiratory viruses, including the novel coronavirus (COVID-19), to Georgian government.
  • As of 12 pm on March 11, 23 people in Georgia had tested positive for the COVID-19.
  • Having learned of the effectiveness of the virus test kit, the embassy of Georgia in China, on behalf of the Georgian government, sought help from the government of Sichuan Province.
  • The Sichuan provincial government assigned the hospital to donate the medical supplies.

Global Isothermal Nucleic Acid Amplification Technology Market Analysis, Trends, and Forecasts 2019-2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 9, 2020
Infectious diseases, Biotechnology, Health, Natural sciences, Molecular biology, Branches of biology, Biology, Amplifiers, Laboratory techniques, Biotechnology, Polymerase chain reaction, Nucleic acid test, NAA

The "Isothermal Nucleic Acid Amplification Technology (INAAT) - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Isothermal Nucleic Acid Amplification Technology (INAAT) - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • Isothermal Nucleic Acid Amplification Technology (INAAT) market worldwide is projected to grow by US$2.2 Billion, driven by a compounded growth of 11.5%.
  • Infectious Diseases, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.2%.
  • Poised to reach over US$2.6 Billion by the year 2025, Infectious Diseases will bring in healthy gains adding significant momentum to global growth.

Global Molecular Diagnostics Market (2019 to 2026) - Featuring Abbott Laboratories, Biomrieux, Danaher Corporation & Exact Sciences Corporation Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 13, 2020
Health, Other Health, Biotechnology, Branches of biology, Biology, Natural sciences, Molecular biology, Molecular diagnostics, Amplifiers, Nucleic acid test, Polymerase chain reaction, Microfluidics, Qiagen

According to the publisher's analysis, the molecular diagnostics global market is estimated to reach $18,668.9 million by 2026 growing at a high single-digit CAGR from 2019 to 2026.

Key Points: 
  • According to the publisher's analysis, the molecular diagnostics global market is estimated to reach $18,668.9 million by 2026 growing at a high single-digit CAGR from 2019 to 2026.
  • The molecular diagnostics global market is a competitive market and all the existing players in this market are involved in developing new and advanced molecular based techniques for diagnosis to maintain their market shares and also acquiring companies for product expansion.
  • The molecular diagnostics global market is segmented based on product, technology, application and end-users.
  • The molecular diagnostics global market by technology is divided into PCR, microarray and microfluidics, isothermal nucleic acid amplification tests, in-situ hybridization, NGS and other technologies.

Japan Nucleic Acid Testing/NAT Market for 100 Assays: 2019 Report - Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 30, 2019
Biotechnology, Genetics, Health, Natural sciences, Molecular biology, Chemistry, Physical sciences, Laboratory techniques, Medical diagnosis, Nucleic acid test, Hybridization probe, Assay

The "Japan Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Japan Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis, Trends, and Forecasts, 2019-2025 - Market to Witness Healthy Growth, Driven by Low-cost Advantages

Retrieved on: 
Wednesday, October 30, 2019
Natural sciences, Molecular biology, Branches of biology, Biology, Amplifiers, Laboratory techniques, Biotechnology, Polymerase chain reaction, Nucleic acid test, NAA

Dublin, Oct. 30, 2019 (GLOBE NEWSWIRE) -- The "Isothermal Nucleic Acid Amplification Technology (INAAT) - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Dublin, Oct. 30, 2019 (GLOBE NEWSWIRE) -- The "Isothermal Nucleic Acid Amplification Technology (INAAT) - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • The Isothermal Nucleic Acid Amplification Technology (INAAT) market worldwide is projected to grow by US$2.2 Billion, driven by a compounded growth of 11.5%.
  • Infectious Diseases, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.2%.
  • Poised to reach over US$2.6 Billion by the year 2025, Infectious Diseases will bring in healthy gains adding significant momentum to global growth.

2019 U.S. Nucleic Acid Testing/NAT Market - Sales and Market Shares of Key Suppliers - ResearchAndMarkets.com

Retrieved on: 
Monday, October 14, 2019
Health, Biotechnology, Molecular biology, Medical diagnosis, Nucleic acid test, Hybridization probe, Market share, Academic disciplines

The "U.S. Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Sales and market shares of leading suppliers.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

2019 France Nucleic Acid Testing/NAT Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing - ResearchAndMarkets.com

Retrieved on: 
Friday, October 11, 2019
Biotechnology, Infectious diseases, Health, Oncology, Branches of biology, Molecular biology, Biology, Life sciences, Nucleic acid test, Hybridization probe, Biochip

The "France Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "France Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing" report has been added to ResearchAndMarkets.com's offering.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.